Abbott's spinal cord stimulator approved for diabetic peripheral neuropathy use

Spinal Tech

The FDA extended its approval for Abbot's Proclaim XR spinal cord stimulator.

Proclaim is now approved for patients with painful diabetic peripheral neuropathy, Abbott said in a Jan. 26 news release. The SCS system also connects to the Abbott's NeuroSphere virtual clinic, which allows for remote communication with physicians.

Abbott's Proclaim SCS was approved for chronic pain treatment in 2019.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers